Neuberger Berman Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $204M | Buy |
|
|||||
|
2025
Q1 | $215M | Buy |
|
|||||
|
2024
Q4 | $175M | Buy |
|
|||||
|
2024
Q3 | $200M | Buy |
|
|||||
|
2024
Q2 | $200M | Buy |
|
|||||
|
2024
Q1 | $173M | Buy |
|
|||||
|
2023
Q4 | $161M | Buy |
|
|||||
|
2023
Q3 | $118M | Buy |
|
|||||
|
2023
Q2 | $110M | Buy |
|
|||||
|
2023
Q1 | $95.5M | Buy |
|
|||||
|
2022
Q4 | $87M | Buy |
|
|||||
|
2022
Q3 | $77M | Sell |
|
|||||
|
2022
Q2 | $113M | Buy |
|
|||||
|
2022
Q1 | $63.4M | Sell |
|
|||||
|
2021
Q4 | $52.4M | Sell |
|
|||||
|
2021
Q3 | $51.6M | Sell |
|
|||||
|
2021
Q2 | $82.3M | Buy |
|
|||||
|
2021
Q1 | $83.3M | Sell |
|
|||||
|
2020
Q4 | $92.7M | Sell |
|
|||||
|
2020
Q3 | $119M | Buy |
|
|||||
|
2020
Q2 | $123M | Buy |
|
|||||
|
2020
Q1 | $91.6M | Buy |
|
|||||
|
2019
Q4 | $83.1M | Buy |
|
|||||
|
2019
Q3 | $63.3M | Buy |
|
|||||
|
2019
Q2 | $66.1M | Buy |
|
|||||
|
2019
Q1 | $64.1M | Buy |
|
|||||
|
2018
Q4 | $42.4M | Buy |
|
|||||
|
2018
Q3 | $48M | Buy |
|
|||||
|
2018
Q2 | $42.2M | Buy |
|
|||||
|
2018
Q1 | $39.9M | Buy |
|
|||||
|
2017
Q4 | $33.7M | Buy |
|
|||||
|
2017
Q3 | $34M | Sell |
|
|||||
|
2017
Q2 | $31.1M | Sell |
|
|||||
|
2017
Q1 | $26.9M | Buy |
|
|||||
|
2016
Q4 | $17.3M | Sell |
|
|||||
|
2016
Q3 | $50.4M | Sell |
|
|||||
|
2016
Q2 | $54.6M | Buy |
|
|||||
|
2016
Q1 | $42.9M | Sell |
|
|||||
|
2015
Q4 | $68M | Buy |
|
|||||
|
2015
Q3 | $53.3M | Buy |
|
|||||
|
2015
Q2 | $59M | Buy |
|
|||||
|
2015
Q1 | $50.4M | Buy |
|
|||||
|
2014
Q4 | $35.4M | Buy |
|
|||||
|
2014
Q3 | $5.49M | Sell |
|
|||||
|
2014
Q2 | $4.85M | Sell |
|
|||||
|
2014
Q1 | $3.74M | Sell |
|
|||||
|
2013
Q4 | $4.22M | Sell |
|
|||||
|
2013
Q3 | $84.7M | Sell |
|
|||||
|
2013
Q2 | $168M | Buy |
|